Episodes 46-60 of 272
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
NeuroFrontiersExamining the Role of Toxic Tau Proteins in Alzheimer's Disease
PBA Treatment May Reverse Signs of Alzheimer’s Disease
NeuroFrontiersPBA Treatment May Reverse Signs of Alzheimer’s Disease
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
NeuroFrontiersAlzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Could Excessive Sleeping Indicate Cognitive Decline in Older Adults?
What Your Patients Are Talking AboutCould Excessive Sleeping Indicate Cognitive Decline in Older Adults?
Key Considerations for CGM Use in Older Adults with T1D
Diabetes DiscourseKey Considerations for CGM Use in Older Adults with T1D
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
NeuroFrontiersDiagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
- advertisement
The Aging HIV Population: Combatting Challenges & Addressing Stigma
Clinician's RoundtableThe Aging HIV Population: Combatting Challenges & Addressing Stigma
A Look at Lecanemab: The Latest Breakthrough in Alzheimer’s Treatment
NeuroFrontiersA Look at Lecanemab: The Latest Breakthrough in Alzheimer’s Treatment
Investigating the Link Between Hypertension Medications & Dementia
NeuroFrontiersInvestigating the Link Between Hypertension Medications & Dementia
Alzheimer’s Disease: What’s The Latest Research?
NeuroFrontiersAlzheimer’s Disease: What’s The Latest Research?
- advertisement
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
NeuroFrontiersDiving into the Debate Surrounding Aducanumab for Alzheimer’s
What to Know About the No Surprises Act
Perspectives with the AMAWhat to Know About the No Surprises Act





































































